Prasol Chemicals Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹434Cr
- +29.6% QoQ
- Net profit
- ₹61Cr
- +205% QoQ
- Margin
- 21%
- +11 pp QoQ
Guidance rank: #27 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Expected top-line growth of around 30-35% for FY27, driven by steady volume growth, better product mix, and higher realizations. Company expects a minimum 70% growth in EBITDA compared to last year, indicating strong operating earnings improvement.
From Prasol Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Expected top-line growth of around 30-35% for FY27, driven by steady volume growth, better product mix, and higher realizations.
- Volume growth may be single-digit, with revenue growth amplified due to increasing sales of higher-value derivatives.
- Most plants expected to cross 70%+ utilization by year-end, with expansion plans underway to meet demand.
- Phase 1 expansion (60,000 tons capacity addition) will incrementally enhance capacities, targeting peak utilization at Khopoli and Mahad facilities.
- Focus on application-based growth rather than just customer-based growth, emphasizing customized product innovation.
- New product pipeline includes antibacterial drugs, mining chemicals, lubricants, with commercial rollouts expected over next 12-18 months.
2 more points from Prasol Chemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
Company expects a minimum 70% growth in EBITDA compared to last year, indicating strong operating earnings…
Locked: what Prasol Chemicals Ltd said on margins
Also locked on this page: fundraising
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
- Phase 1 Expansion Capex: INR 250-300 crores focused on existing products.
- Land and Infrastructure: INR 50-60 crores directed towards land purchase and infrastructure development (land already purchased).
- Storage Facility: Approximate INR 25 crores allocated for new storage tanks with floating roof at Khopoli to store raw materials like acetone.
- R&D Lab Expansion: Additional 4,000 sq. ft. special application lab under construction, with an investment of INR 15-20 crores.
- New Products: Investment in 10-14 products with staggered commissioning over 12-18 months; includes antibacterial drug plant completion by January and lubricant capacity increase through debottlenecking.
2 more points from Prasol Chemicals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
The company is undertaking capex of INR 250-300 crores for Phase 1 expansion, funded through internal…
Locked: what Prasol Chemicals Ltd said on fundraising
Also locked on this page: margins
Free account, 30 seconds. No card needed.
Order Book & Pipeline
- The company indicates strong demand with orders leading to capacity utilization rising from 12% to over 60% at the Mahad plant.
- The company has around 10 to 14 new products in the pipeline expected to come online in the next 12 to 18 months, suggesting a healthy order flow.
- There is ongoing expansion with Phase 1 capex of INR 250-300 crores to support increased production capacity responding to order growth.
2 more points from Prasol Chemicals Ltd's call on order book
Create a free account to keep reading this call
Prasol Chemicals Ltd — Quarterly revenue & net profit
Prasol Chemicals Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q4 FY26 | QoQ |
|---|---|---|---|
| Revenue | 434 | 335 | +29.6% |
| Operating profit (EBITDA) | 90 | 32 | +181.3% |
| Operating margin | 21% | 10% | +11 pp |
| Profit before tax | 84 | 27 | +211.1% |
| Net profit (PAT) | 61 | 20 | +205% |
| EPS (₹) | 10.52 | 3.42 | +207.6% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹413 Cr, net profit ₹38 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Prasol Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Prasol Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Prasol Chemicals Ltd Q1 FY27 results?
Expected top-line growth of around 30-35% for FY27, driven by steady volume growth, better product mix, and higher realizations. Company expects a minimum 70% growth in EBITDA compared to last year, indicating strong operating earnings improvement.
What is Prasol Chemicals Ltd share price analysis?
Prasol Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 36.3 with a market cap of ₹4,376 Cr. Investors should review the full earnings analysis for detailed insights.
Is Prasol Chemicals Ltd planning capital expenditure?
Phase 1 Expansion Capex: INR 250-300 crores focused on existing products. - Land and Infrastructure: INR 50-60 crores directed towards land purchase and infrastructure development (land already purchased). - Storage Facility: Approximate INR 25 crores allocated for new storage tanks with floating roof at Khopoli to store raw materials like acetone. - R&D Lab Expansion: Additional 4,000 sq.
Keep Prasol Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.